BiomX (PHGE) EBIT (QoQ) (2018 - 2026)
BiomX (PHGE) EBIT (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.69% |
| Dec 31, 2025 | -107.84% |
| Sep 30, 2025 | -14.84% |
| Jun 30, 2025 | 4.16% |
| Mar 31, 2025 | 53.52% |
| Dec 31, 2024 | -47.29% |
| Sep 30, 2024 | -16.48% |
| Dec 31, 2023 | 32.37% |
| Sep 30, 2023 | -28.36% |
| Jun 30, 2023 | 2.17% |
| Mar 31, 2023 | -11.65% |
| Dec 31, 2022 | 15.10% |
| Sep 30, 2022 | 10.58% |
| Jun 30, 2022 | 5.93% |
| Mar 31, 2022 | 20.43% |
| Dec 31, 2021 | 0.49% |
| Sep 30, 2021 | -34.66% |
| Jun 30, 2021 | 14.52% |
| Mar 31, 2021 | 5.80% |
| Dec 31, 2020 | -2.70% |